tm logo
CONSTELLATION
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 05 Nov 2024

Last Applicant/ Owned by

215 First Street, Suite 200

Cambridge

MA

02142

Serial Number

87888540 filed on 23rd Apr 2018

Registration Number

N/A

Correspondent Address

KEITH TOMS

KEITH TOMS MCCARTER & ENGLISH LLP

BOSTON, MA 02110

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CONSTELLATION

Pharmaceutical research and development; Research and development in the fields of genetics, pharmaceuticals, cancer, epigenetics, and immune-oncology, all of the foregoing for the purposes of drug development; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical products development Pharmaceutical preparations Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development; Research and development in the fields of genetics, pharmaceuticals, cancer, epigenetics, and immune-oncology, all of the foregoing for the purposes of drug development; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical products development


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of cancer, inflammatory, and fibrotic disorders; pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceutical preparations for the treatment of lymphomia, solid cancers, blood disease, myelofibrosis, Alzheimer's disease, arthritis, Sjogren's syndrome, autoimmune hepatitis, systemic lupus erythematosus, venus thromboembolism (VTE), cancer associated thrombosis (CAT), renal autoimmune disease, pulmonary sarcoidosis, severe atopic dermatitis, diabetes, asthma, chronic obstructive pulmonary disease (COPD)


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 87888540

Mark Type

No Service Mark

Attorney Docket Number

No 124033-90101

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Nov 2024SOU EXTENSION 4 FILED
05th Nov 2024SOU EXTENSION 4 GRANTED
05th Nov 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Nov 2024SOU TEAS EXTENSION RECEIVED
07th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06th May 2024SOU EXTENSION 3 FILED
06th May 2024SOU TEAS EXTENSION RECEIVED
06th May 2024SOU EXTENSION 3 GRANTED
09th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Nov 2023SOU EXTENSION 2 FILED